Skip to main content

Correction: ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma

The Original Article was published on 27 July 2023

Correction: J Exp Clin Cancer Res 42, 182 (2023)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-023-02751-9


Following the publication of the original article [1], the author identified an error in Fig. 5, specifically, Fig. 5A. The GAPDH strip was misuse and is the same with Fig. 8A.

The correct figure is presented below:

Incorrect Fig. 5

Fig. 5
figure 1

The overexpression of ISGylation promoted CSCs characteristics. A The overexpression efciency of ISGylation-WT/AA analyzed by western blot. B The cell viability, (C) sphere formation and (D) mRNA level of OCT4, NANOG and CD133 of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression. E The cell viability of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression combined with doxorubicin for 48 h. F The mRNA level of ABCB1 and ABCC1 of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression

Correct Fig. 5

Fig. 5
figure 2

The overexpression of ISGylation promoted CSCs characteristics. A The overexpression efciency of ISGylation-WT/AA analyzed by western blot. B The cell viability, (C) sphere formation and (D) mRNA level of OCT4, NANOG and CD133 of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression. E The cell viability of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression combined with doxorubicin for 48 h. F The mRNA level of ABCB1 and ABCC1 of 8505 C or KHM5M cells after ISGylation-WT/AA overexpression

The correction does not compromise the validity of the conclusions and the overall content of the article. The original article [1] has been updated.

Reference

  1. Xu T, Zhu C, Chen J, et al. ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. J Exp Clin Cancer Res. 2023;42:182. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-023-02751-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Zongfu Pan, Ping Huang or Minghua Ge.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, T., Zhu, C., Chen, J. et al. Correction: ISG15 and ISGylation modulates cancer stem cell-like characteristics in promoting tumor growth of anaplastic thyroid carcinoma. J Exp Clin Cancer Res 43, 301 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-024-03226-1

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13046-024-03226-1